Literature DB >> 18544200

Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?

I Dubrovina1, K Miskinis, S Lyepshina, Y Yann, H Hoffmann, R Zaleskis, P Nunn, M Zignol.   

Abstract

OBJECTIVE: To investigate anti-tuberculosis (TB) drug resistance rates in Donetsk Oblast, Ukraine, and to explore the association between the epidemics of human immunodeficiency virus (HIV) and multidrug-resistant TB (MDR-TB).
METHODS: All consecutive newly diagnosed and previously treated patients with sputum smear-positive TB presenting to all TB units in Donetsk Oblast over 12 months were invited to take part in the study. A total of 1293 and 203 patients with TB were tested for HIV and MDR-TB in the civilian and penitentiary sectors, respectively.
RESULTS: Of those enrolled for the study, 307 were HIV-positive, 379 had MDR-TB, and 97 had MDR-TB and HIV co-infection. MDR-TB rates in the civilian sector were respectively 15.5% (95%CI 13.1-17.8) and 41.5% (95%CI 36.4-46.5) in newly diagnosed and previously treated TB patients. Among prisoners, MDR-TB rates were 21.8% (95%CI 12.4-31.2) in new cases and 52.8% (95%CI 43.9-61.7) in previously treated TB cases. HIV status was significantly associated with MDR-TB (OR 1.7, 95%CI 1.3-2.3).
CONCLUSIONS: High MDR-TB rates and a positive association between MDR-TB and HIV epidemics were found in Donetsk Oblast. Urgent measures to improve HIV prevention, control of drug-resistant TB and collaboration between HIV and TB control activities need to be implemented without further delay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544200

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  24 in total

1.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

2.  Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling.

Authors:  Bethany Lynn Hedt; Frank van Leth; Matteo Zignol; Frank Cobelens; Wayne van Gemert; Nguyen Viet Nhung; Svitlana Lyepshina; Saidi Egwaga; Ted Cohen
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

3.  Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.

Authors:  James C M Brust; N Sarita Shah; Koleka Mlisana; Pravi Moodley; Salim Allana; Angela Campbell; Brent A Johnson; Iqbal Master; Thuli Mthiyane; Simlatha Lachman; Lee-Megan Larkan; Yuming Ning; Amyn Malik; Jonathan P Smith; Neel R Gandhi
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

4.  Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011.

Authors:  H E Jenkins; M Gegia; J Furin; I Kalandadze; U Nanava; T Chakhaia; T Cohen
Journal:  Euro Surveill       Date:  2014-03-20

Review 5.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

6.  Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.

Authors:  L T Daum; O S Konstantynovska; O S Solodiankin; O O Liashenko; P I Poteiko; V I Bolotin; I I Hrek; A V Rohozhyn; J D Rodriguez; G W Fischer; J P Chambers; A P Gerilovych
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

7.  Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.

Authors:  Olga Morozova; Sergii Dvoryak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2013-09-09

Review 8.  Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community.

Authors:  Sheela Shenoi; Scott Heysell; Anthony Moll; Gerald Friedland
Journal:  Curr Opin Infect Dis       Date:  2009-02       Impact factor: 4.915

Review 9.  Epidemiology of HIV-associated tuberculosis.

Authors:  Stephen D Lawn; Gavin Churchyard
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

10.  Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.

Authors:  Helen E Jenkins; Valeriu Plesca; Anisoara Ciobanu; Valeriu Crudu; Irina Galusca; Viorel Soltan; Aliona Serbulenco; Matteo Zignol; Andrei Dadu; Masoud Dara; Ted Cohen
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.